Enter your login e-mail to the account
Search
Search parameters
Search results
- Pharmacotherapy of rheumatoid arthritis II. – biological therapy
doc. MUDr. Želmíra Macejová, PhD., doc. MUDr. Ivan Rybár, PhD.
(2/2010, Drugs & drug classes ) - Systemic lupus erythematosus – an overview of new knowledge in pathogenesis, clinical picture and treatment
doc. Ing. Stanislava Blažíčková, PhD., prof. MUDr. Jozef Rovenský, DrSc., FRPC, MUDr. Ivana Stiborová
(2/2012, Review articles ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - TAKAYASU´S ARTERITIS
prof. MUDr. Viera Štvrtinová, CSc.
(1/2008, Topic ) - Crohn´s disease
doc. MUDr. Martin Huorka, CSc.
(3/2009, Review articles ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(2/2017, Interdisciplinary consilium ) - CURRENT VIEW OF PATHOGENESIS AND THERAPY OF ACNE
MUDr. Dušan Buchvald, PhD.
(3/2005, Topic ) - Biologics for rheumatoid arthritis treatment
prof. MUDr. Juraj Payer, CSc., MUDr. Daniel Čierny, doc. MUDr. Zdenko Killinger, PhD., MUDr. Kristína Brázdilová
(9/2009, Review articles ) - Tlačové správy
(4/2010, Information & comments ) - RANIBIZUMAB – NEW OPTION IN TREATMENT OF AGE RELATED MACULAR DEGENERATION
MUDr. Martin Černák, PhD., prof. MUDr. Andrej Černák, DrSc.
(11/2008, Medicine ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - FOLLICULAR LYMPHOMA
MUDr. Adriana Kafková
(12/2008, Topic ) - CHRONIC LYMPHOCYTIC LEUKEMIA
prof. MUDr. Elena Tóthová, CSc.
(12/2008, Topic )
- Výzkum nových léčiv u Alzheimerovy choroby
PharmDr. Jana Hroudová, Ph.D.
(2/2018, Review articles )
- Experience with shortened ocrelizumab infusion – ENSEMBLE PLUS study
doc. MUDr. Yvonne Benešová, Ph.D.
(1/2022, Review articles ) - Alemtuzumab treatment in multiple sclerosis: real clinical experience
MUDr. Viktória Halušková, MUDr. Zbyšek Pavelek, PhD., doc. MUDr. Martin Vališ, Ph.D.
(5/2019, Case reports ) - Anti CD20 multiple sclerosis therapy
Doc. MUDr. Pavel Štourač, Ph.D.
(1/2018, Pharmacotherapy ) - Efficacy and safety of ocrelizumab in multiple sclerosis
MUDr. Radek Ampapa
(5/2017, Review articles ) - Long term efficacy of ocrelizumab on MRI parameters in multiple sclerosis patients
MUDr. Pavel Hradílek, Ph.D.
(1/2020, Review articles ) - The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - The first administration of idarucizumab with subsequent intravenous thrombolysis and mechanical thrombectomy in Slovakia (a case report)
MUDr. Oto Petrík, MPH, MUDr. Iuliia Travkina, MUDr. Rastislav Bažík, MUDr. Ivan Vulev, PhD., MPH, FCIRSE, MUDr. Eva Unčovská
(5/2018, Case reports ) - Ocrelizumab – pharmacoloical profile
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(5/2018, Pharmacotherapy ) - Pharmacology, efficacy and safety of natalizumab in an extended interval dosing
doc. MUDr. Ema Kantorová, PhD.
(4/2023, Informations ) - The significance of correct algorithm of the diagnostics and treatment of migraine in the prophylactic treatment against calcitonin gene-related peptide
MUDr. Rudolf Kotas, Ph.D., MUDr. Ondřej Slach, MUDr. František Jelínek, MUDr. Jolana Mračková, Ph.D.
(2/2022, Review articles ) - Current options in the treatment of multiple sclerosis
MUDr. Eva Meluzínová
(5/2010, Review articles ) - Clinical experience with alemtuzumab
MUDr. Eva Meluzínová, MUDr. Jana Libertínová, MUDr. Petra Lišková
(3/2016, Case reports ) - Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective
Prof. MUDr. Tomáš Kozák, Ph.D.
(6/2016, From the boundary of neurology ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Magnetic resonance imaging for detection of opportunistic infection of patients with multiple sclerosis
doc. MUDr. Dana Horáková, Ph.D., prof. MUDr. Manuela Vaněčková, Ph.D.
(6/2016, Review articles ) - Biological therapy by Ocrelizumab (antiCD20) is surprisingly clinically effective in multiple sclerosis patients
Prof. RNDr. Jan Krejsek, CSc.
(6/2017, From the boundary of neurology ) - Long-term data of multiple sclerosis treatment with ocrelizumab – eficacy, safety and clinical experience
MUDr. Mgr. Matouš Rous, MUDr. Zuzana Rous, Ph.D.
(6/2021, Review articles ) - Ocrelizumab – what we know, what we can improve now, what we can improve in the future
MUDr. Martin Elišák, Ph.D.
(1/2024, Review articles ) - Ofatumumab in clinical practice
MUDr. Martin Elišák, Ph.D.
(1/2024, Review articles ) - Progress in therapy of autoimmune neuropathies
doc. MUDr. Edvard Ehler, CSc. , prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN
(3/2021, Main topic ) - Treatment persistence to ocrelizumab and local experience
MUDr. Simona Halúsková, prof. MUDr. Martin Vališ, Ph.D., FEAN
(3/2021, Review articles ) - Efficacy and safety of ofatumumab in naive MS patients.
MUDr. Martina Martiníková
(5/2023, Informations ) - Listeria meningitis after administration of alemtuzumab for relapsing-remitting multiple sclerosis
MUDr. Pavel Hradílek, Ph.D., MUDr. Petr Hon
(3/2017, Case reports ) - COVID-19 in patients with multiple sclerosis treated with ofatumumab
MUDr. Eva Recmanová
(2/2023, Review articles ) - Alemtuzumab in multiple sclerosis treatment
MUDr. Eva Meluzínová
(4/2015, Pharmacotherapy ) - Ocrelizumab – long-term efficacy and safety in real-world clinical practice in patients with relapsingremitting multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(3/2022, Review articles ) - New perspective treatment of multiple sclerosis
doc. MUDr. Vladimír Donáth, CSc., MUDr. Silvia Laurincová
(2/2014, Main topic ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(4/2016, Review articles ) - Peripheral neuropathies in malignancies
prof. MUDr. Zdeněk Ambler, DrSc.
(5/2013, Review articles ) - Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis
MUDr. Marek Peterka
(6/2022, Review articles ) - Eptinezumab – the new anti-CGRP monoclonal antibody for prophylactic treatment of migraine
MUDr. Rudolf Kotas, Ph.D.
(6/2022, Review articles ) - Shorter infusion of ocrelizumab in the treatment of multiple sclerosis
MUDr. Marek Peterka , MUDr. Pavel Potužník
(4/2021, Review articles ) - Treatment with the monoclonal antibody alemtuzumab: effect on the manifestation of thyroid disorders
Prof. MUDr. Petr Vlček, CSc., RNDr. Dana Nováková
(4/2017, From the boundary of neurology ) - Ocrelizumab v léčbě roztroušené sklerózy
Prof. MUDr. Eva Kubala Havrdová, CSc.
(4/2017, Pharmacotherapy ) - Clinical experiences in multiple sclerosis patients treated with alemtuzumab
MUDr. Mária Ďurišová, MUDr. Eva Recmanová
(2/2020, Case reports ) - Does the development of new drugs for multiple sclerosis change the prognosis of the patient?
prof. MUDr. Eva Havrdová, CSc.
(3/2011, Review articles ) - Ocrelizumab and novel therapeutic goals in multiple sclerosis
MUDr. Radek Ampapa
(2/2020, Review articles )
- Severe asthma in childhood
doc. MUDr. Peter Čižnár, CSc.
(4/2013, Review articles ) - CHRONIC ABDOMINAL PAIN IN CHILDREN
MUDr. Vladimír Volf, Ph.D.
(3/2006, Review articles ) - Anti-IgE therapy of severe asthma in children and adolescents
doc. MUDr. Peter Čižnár, CSc.
(3/2012, Case reports )
- Management of the metastatic renal cancer
doc. MUDr. Jaroslav Pacovský, Ph.D.
(1/2023, Review articles )
- Klinická skúsenosť s liečbou mnohopočetného myelómu monoklonálnou protilátkou v monoterapii – kazuistika
MUDr. Natália Štecová
(4/2018, Original articles ) - Daratumumab across multiple myeloma treatment lines
MUDr. Juliana Holasová, Doc. MUDr. Ľubica Harvanová, PhD., MUDr. Iveta Simančíková, MUDr. Miriam Ladická, MUDr. Ľudmila Demitrovičová, PhD., MUDr. Emília Flochová, PhD., MUDr. Juraj Chudej, PhD., MBA, MUDr. Natália Štecová, PhD., MUDr. Tomáš Guman, PhD., MUDr. Alexander Wild, PhD.
(6/2023, Drugs & drug classes ) - Sacituzumab govitekan – drug profile
MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Drugs & drug classes ) - Variant hairy cell leukemia in complete remision after treatment of rituximab and fludarabine – case report
MUDr. Radoslav Greksák, PhD.
(5/2018, Original articles & case reports ) - Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Systemic treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(3/2013, Main topic ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Gastrointestinal stromal tumors
MUDr. Jozef Šufliarsky, PhD.
(1/2011, Review articles ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - SPRÁVA Z 30. SAN ANTONIO BREAST CANCER SYMPOSIUM, 13. – 16. DECEMBER 2007
MUDr. Vladimír Malec
(1/2008, Review articles ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - 19. MEDZINÁRODNÁ KONFERENCIA ICACT 5. – 8. 2. 2008, PARÍŽ
MUDr. Tomáš Šálek
(1/2008, Events ) - Enfortumab vedotin in advanced urothelial carcinoma treatment
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(5/2021, Drugs & drug classes ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Biological treatment with monoclonal antibody
MUDr. Andrey Švec, PhD., PharmDr. Andrea Gažová, PhD., prof. PharmDr. Ján Kyselovič, CSc.
(2/2019, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - New trends in the immunotherapy of cancer
MUDr. Ján Lakota, CSc.
(6/2016, Review articles ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Ipilimumab in the treatment of malignant melanoma
MUDr. Róbert Godál
(3/2011, Drugs & drug classes ) - Cetuximab – a chimeric monoclonal IgG1 antibody for the treatment of patients with squamous cell cancer of the head and neck
doc. PharmDr. Juraj Sýkora, CSc.
(6/2009, Drugs & drug classes ) - Treatment and prognosis of patients with hairy cell leukaemia treated in 1996 – 2010 at the National Cancer Institute in Bratislava
MUDr. Miriam Ladická, MUDr. Ľudmila Demitrovičová, MUDr. Radoslav Greksák, PhD., MUDr. Iveta Oravcová, PhD.
(4/2011, Original articles & case reports ) - Exon 20 insertions and other uncommon EGFR mutations in non-small cell lung cancer
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(4/2023, Review articles ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - WALDENSTRÖM‘S MACROGLOBULINEMIA – EPIDEMIOLOGY, ETHIOPATOGENESIS, DIAGNOSTIC AND TREATMENT
prof. MUDr. Elena Tóthová, CSc.
(5/2008, Review articles ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Olaratumab – liečba pre pacientov s pokročilým sarkómom mäkkých tkanív nevhodných na chirurgickú liečbu alebo rádioterapiu
MUDr. Peter Zuzák
(3/2018, Drugs & drug classes ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Biological therapy in colorectal cancer
MUDr. Jozef Dolinský
(2/2011, Review articles ) - Experience with obinutuzumab in patients with chronic lymphocy
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(6/2017, Original articles & case reports ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - Publikujeme v zahraničí
(2/2013, Information & comments ) - Ipilimumab – new drug, new experience
MUDr. Zuzana Hlavatá, PhD.
(5/2013, Original articles & case reports ) - Use of nivolumab in solid tumours
MUDr. Katarína Bahnová
(4/2024, Review articles ) - BONE SARKOMAS
MUDr. Peter Múdry
(6/2008, Review articles ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Antitumor immunity
MUDr. Ján Lakota, CSc., MUDr. Milan Žuffa, CSc.
(2/2015, Review articles ) - The current status of biological therapy for relapsed/refractory classical hodgkin lymphoma – a case report
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2015, Original articles & case reports ) - Establishing diagnosis of hairy cell leukemia (HCL) and identification of the extent of the minimal residual disease (MRD) with flow cytometry of bone marrow aspirate and immunochemistry of trephine biopsy
MUDr. Radoslav Greksák, PhD.
(6/2012, Original articles & case reports ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Publikujeme v zahraničí
(1/2017, Information & comments ) - Current treatment trends for multiple myeloma – subcutaneous administration of proteasome inhibitor
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Janka Baňáková, MUDr. Hilda Šajgalíková, MUDr. Miroslav Šimek, PhD.
(2/2014, Review articles ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - TESTICULAR TUMOR IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS. DIFFERENCES IN BIOLOGY ACROSS THE AGE
MUDr. Viera Bajčiová, CSc.
(6/2007, Review articles ) - Treatment metastatic gastric cancer
MUDr. Vanda Ušáková, PhD.
(1/2018, Review articles ) - CONTEMPORARY POSSIBILITY OF THE TREATMENT OF BONE METASTASES
prof. MUDr. Ľudovít Jurga, CSc.
(3/2007, Review articles - treatment ) - Publikujeme v zahraničí
(1/2018, Information & comments ) - Interference with NAT in the treatment of multiple myeloma by monoclonal antibody
MUDr. Marta Kučeráková, MUDr. Mária Laurincová, Mgr. Jana Holienková, Mgr. Jana Králová, MUDr. Martin Písačka
(5/2018, Review articles )
- Výber abstraktov zo XIV. kongresu slovenských a českých dermatovenerológov s medzinárodnou účasťou, Jasná 2018
redakcia
(3/2018, Abstracts ) - Progress in the biological treatment of psoriasis
Prof. MUDr. Mária Šimaljaková, PhD
(1/2018, Drugs & drug classes ) - Novinky v dermatoonkológii
(1/2018, Information & comments ) - Ustekinumab in treating psoriatic arthritis
MUDr. Jiří Štolfa, MUDr. Hana Ciferská, Ph.D.
(4/2015, Review articles ) - Cutaneous complications of the 1. line immunomodulators in the Multiple Sclerosis treatment
doc. MUDr. Eleonóra Klímová, CSc., MUDr. Adrián Ryník, MUDr. Monika Daňová, PhDr. Andrea Lengyelová
(1/2013, Interdisciplinary consilium ) - Adalimumab – long-term safety and new indications in dermatology
MUDr. Veronika Slonková, Ph.D., prof. MUDr. Vladimír Vašků, CSc.
(2/2015, Review articles ) - BIOLOGICA TREATMENT OF PSORIATIC ARTHRITIS
MUDr. Liliana Šedová, MUDr. Jiří Štolfa
(2/2007, Interdisciplinary overviews ) - View of clinical immunology on targeted therapy of psoriasis
doc. MUDr. Martin Hrubiško, PhD.
(1/2012, Interdisciplinary consilium )
- Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - Biological drugs from the perspective of pharmacy
PharmDr. Katarína Bruchatá, PhD., Mgr. Peter Heinz
(4/2014, Pharmaceutical technology ) - Infliximab
Doc. MUDr. Karel Urbánek, Ph.D.
(4/2017, Drug profile ) - The current possibilities of the treatment of bronchial asthma
prof. MUDr. Eva Rozborilová, CSc., prof. MUDr. Gabriela Nosáľová, DrSc.
(2/2012, Current pharmacotherapy )
- The importance of Chlamydophila pneumoniae and cytomegalovirus infection in development of carotid plaques
MUDr. Roman Slyško, PhD., MUDr. Ján Tomka, PhD., prof. MUDr. Vladimír Šefránek, PhD., MUDr. Ján Kazár, DrSc., Mgr. Juraj Gašparovič, MUDr. Eva Kováčová, PhD., MUDr. Katarína Daňová
(2/2010, Review articles ) - Emicizumab, a new era in the treatment for patients with haemophilia A
MUDr. Tomáš Šimurda, PhD., Ing. Ingrid Škorňová, PhD., prof. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc., MUDr. Monika Brunclíková, MUDr. Alena Strýčková
(2/2019, Drugs & drug classes )